Paper19856484
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.
Matsushita Y and 7 others. Pharmacoepidemiol Drug Saf, 2010. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan. Papers, record 19856484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19856484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticholesteremic Agents | Major topic |
| Neoplasms | Major topic |
| Pravastatin | Major topic |
| Controlled Clinical Trials as Topic | |
| Female | |
| Humans | |
| Japan | |
| Male | |
| Middle Aged | |
| Risk Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 20101642 | Commentary on pravastatin and cancer: need for individual patient data meta-analyses. | https://conductscience.org/library/papers/20101642 |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38284728 | Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review. | Recent Pat Anticancer Drug Discov | 2025 | https://conductscience.org/library/papers/38284728 | PubMed |
| 37894467 | Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894467 | PubMed |
| 36672322 | Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672322 | PubMed |
| 36498753 | Statins and the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498753 | PubMed |
| 36229904 | Statin Intake and Gastric Cancer Risk: An Updated Subgroup Meta-analysis Considering Immortal Time Bias. | J Prev Med Public Health | 2022 | https://conductscience.org/library/papers/36229904 | PubMed |
| 35989795 | Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review. | Cureus | 2022 | https://conductscience.org/library/papers/35989795 | PubMed |
| 35356132 | A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. | Can J Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35356132 | PubMed |
| 35154535 | The role of statins in lung cancer. | Arch Med Sci | 2022 | https://conductscience.org/library/papers/35154535 | PubMed |
| 34970858 | Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis. | Cancer Med | 2022 | https://conductscience.org/library/papers/34970858 | PubMed |
| 33654016 | Statins for treatment of chronic liver disease. | Curr Opin Gastroenterol | 2021 | https://conductscience.org/library/papers/33654016 | PubMed |
| 32260179 | Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32260179 | PubMed |
| 32183029 | Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32183029 | PubMed |
| 31513091 | Statin therapy: does sex matter? | Menopause | 2019 | https://conductscience.org/library/papers/31513091 | PubMed |
| 31426090 | Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. | Ann Intern Med | 2019 | https://conductscience.org/library/papers/31426090 | PubMed |
| 31041062 | Statins and metformin for chemoprevention of hepatocellular carcinoma. | Clin Liver Dis (Hoboken) | 2016 | https://conductscience.org/library/papers/31041062 | PubMed |
| 29770171 | Risk of gastric cancer development after eradication of Helicobacter pylori. | World J Gastrointest Oncol | 2018 | https://conductscience.org/library/papers/29770171 | PubMed |
| 27468210 | Pleiotropic effects of statins in the diseases of the liver. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27468210 | PubMed |
| 27198922 | Meta-analysis of studies using statins as a reducer for primary liver cancer risk. | Sci Rep | 2016 | https://conductscience.org/library/papers/27198922 | PubMed |
| 25904829 | Effects of statins on the risk of hepatocellular carcinoma. | Gastroenterol Hepatol (N Y) | 2014 | https://conductscience.org/library/papers/25904829 | PubMed |
| 25722350 | Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25722350 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19856484
GET https://conductscience.org/api/papers/v1/19856484/cited_by?page=2